NCT02727205
- Conditions
- Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch
- Locations
-
- Clinical Pharmacology of Miami, Inc. Miami, Florida, United States
- Inflamax Research Inc. Mississauga, Ontario, Canada
Clinical trial condition
Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch
Explore clinical trials studying Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies